Morphine Sulfate — 8MG/20ML, Injection, package of 25 × 1 mL vials

Morphine Sulfate — 8MG/20ML, Injection, package of 25 × 1 mL vials

Morphine Sulfate is a injection for intravenous use. Morphine Sulfate Injection is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use : Because of the risks of addiction, abuse, and misuse with opioids, which can occur at any dosage or duration [see Warnings and Precautions (5.1) ] , reserve Morphine Sulfate Injection for use in patients for whom alternative treatment options [e.g., non-opioid analgesics or opioid combination products]: Have not been tolerated, or are not expected to be tolerated, Have not provided adequate analgesia or are not expected to provide adequate analgesia.

• Active ingredient or product type: MORPHINE SULFATE
• Strength/concentration: 8MG/20ML
• Dosage form and route: Injection, Intravenous
• Exact package presentation: package of 25 × 1 mL vials
• NDC/item number: 0641-6126-25
• Manufacturer: HIKMA PHARMACEUTICALS USA INC
• Storage/handling: Store at 20ºC to 25°C (68°F to 77°F) [See USP Controlled Room Temperature] until ready to use. PROTECT FROM LIGHT . DO NOT FREEZE .
• Status: Rx only

Important safety information: Cardiovascular Instability : High doses are excitatory.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.